About Angiography Devices
Coronary artery disease (CAD), a type of cardiovascular disease, is one of the leading causes of deaths worldwide, which is accounting for high number of heart attacks, stroke, and death. The formation of plaque in the blood vessels can cause CAD. The disease causes narrowing of the blood vessels, which interrupts normal blood flow and may lead to ischemic stroke. For treatment, physicians may perform angioplasty using balloon catheters with or without stents to open the arteries and improve the blood flow. These diseases are related to the heart and blood vessels. Coronary artery disease causes blockage in the artery characterized by the deposition of fatty substances that leads to the narrowing of blood vessels, and thereby interrupting the supply of normal blood flow to the heart. In an August 2015 report, the Centers of Disease Control and Prevention (CDC) estimated that coronary artery disease causes 370,000 deaths annually.
Technavio’s analysts forecast the global angiography devices market to grow at a CAGR of 6.06% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global angiography devices market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of angiography devices.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Angiography Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Abbott Laboratories
• Boston Scientific
• Cardinal Health
• Medtronic
Other prominent vendors
• Abiomed
• Aachen Resonance
• Acrostak
• Advansource Biomaterials
• AGA Medical
• Allium Medical
• Alvimedica Medical devices
• AMG International
• Angioslide
• AngioDynamics
• Arstasis
• Arthesys
• Asahi Intecc
• Atrium Medical
• AV Medical
• B. Braun Melsungen
• Beijing Puyishengji Medical Technology
• Biophan Technologies
• Biosense Webster
• Biotronik
• BrosMed
• Cardiac Science
• CardiacAssist
• Cardica
• Cardio-Flow
• Cardionovum
• Claret Medical
• Contego Medical
• Cook Group
• Cryolife
• Endocor
• Edward Lifesciences
• Essential Medical
• GaltNeedleTech
• Kaneka Medix
• InSeal Medical
• Innovative Cardiovascular Solutions
• JOTEC
• Keystone Heart
• Lepu Medical Technology
• Medinol
• Medeon Biodesign
• Morris Innovative
• Merit Medical Systems
• Meril Life Sciences
• MicroPort Scientific
• Natec Medical
• OptiMed
• QT Vascular
• SHOCKWAVE Medical
• Smiths Medical
• Spectranetics
• STENTYS
• Svelte medical
• Teleflex
• Tokai Medical
• Transverse Medical
• Transluminal Technologies
• US Endovascular
• Vascular Closure Systems
• Vasorum
• Vivasure Medical
• Volcano
Market driver
• Rising incidences of cardiac diseases increasing adoption of angiography devices
• For a full, detailed list, view our report
Market challenge
• Lack of product differentiation leading to marginal profits
• For a full, detailed list, view our report
Market trend
• Transforming marketing and sales strategies
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by product
• Angioplasty balloons market
• Vascular closure device
• Vascular guidewire
• Embolic protection devices
PART 07: Market segmentation by end user
• ASCs
• Hospitals
• Physicians' offices
PART 08: Geographical segmentation
• Angiography devices market in Americas
• Angiography devices market in EMEA
• Angiography devices market in APAC
PART 09: Market drivers
• Rising incidences of cardiac diseases increasing adoption of angiography devices
• Presence of specialized cardiologists
• Outsourcing research to CROs
• Venture capitals for market entry of start-ups
• Minimally invasive procedures with improved medical imaging
PART 10: Impact of drivers
PART 11: Market challenges
• High cost of angiography devices and procedures
• Product recalls
• Lack of product differentiation leading to marginal profits
PART 12: Impact of drivers and challenges
PART 13: Market trends
• Transforming marketing and sales strategies
• Increase in M&A
• Emergence of digital cath labs in hospitals
PART 14: Vendor landscape
• Competitive landscape analysis
PART 15: Key vendor analysis
• Abbott Laboratories
• Boston Scientific
• Cardinal Health
• Medtronic
• Key companies to watch
• Other prominent vendors
PART 16: Appendix5
• List of abbreviations
PART 17: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global angiography devices market: Overview
Exhibit 03: Angioplasty devices market by product type 2016
Exhibit 04: Scope of angiography devices market based on geography 2017-2021
Exhibit 05: Global angiography devices market: Impact assessment
Exhibit 06: Global angiography devices market 2016-2021 ($ billions)
Exhibit 07: Few key market developments
Exhibit 08: Five forces analysis
Exhibit 09: Global angiography devices market by product 2016-2021 ($ billions)
Exhibit 10: Market overview: Angioplasty balloon
Exhibit 11: Key focus and strategies of companies: Angioplasty balloon
Exhibit 12: Global angioplasty balloons market 2016-2021 ($ billions)
Exhibit 13: Clinical study: Difference in stenosis of DEBs
Exhibit 14: Market overview: Vascular closure device
Exhibit 15: Key focus and strategies of companies: Vascular closure device
Exhibit 16: Global vascular closure devices market 2016-2021 ($ billions)
Exhibit 17: Market overview and focus of companies: Vascular guidewire
Exhibit 18: Key focus and strategies of companies: Vascular guidewire
Exhibit 19: Global vascular guidewires market 2016-2021 ($ billions)
Exhibit 20: Market overview and focus of companies: Embolic protection device
Exhibit 21: Key focus and strategies of companies: Embolic protection device
Exhibit 22: Global embolic protection devices market 2016-2021 ($ billions)
Exhibit 23: Some advanced embolic protection devices
Exhibit 24: New entrants and milestone achieved by them
Exhibit 25: Embolic protection devices: Clinical studies with positive results
Exhibit 26: Global angiography devices market in 2016
Exhibit 27: Comparison of reimbursement for ASCs, hospital out-patient departments, and physicians' offices in US
Exhibit 28: Coronary angioplasty same day basis procedure in hospitals and ASCs in Europe
Exhibit 29: Global angiography devices market by geography in 2016 and 2021 ($ billions)
Exhibit 30: Market overview: Angiography devices market in Americas
Exhibit 31: Number of coronary angiography in few countries in Americas 2013
Exhibit 32: Angiography devices market in Americas 2016-2021 ($ billions)
Exhibit 33: Angiography devices market in Americas: Metrics analysis for various countries
Exhibit 34: Market overview: Angiography devices market in the US
Exhibit 35: Implements amended in ACA in US (in 2010 and 2014-2015)
Exhibit 36: Impact of Accountable Care Organization (ACO) and ACA on angiography devices
Exhibit 37: Market overview: Angiography devices market in EMEA
Exhibit 38: Number of coronary revascularization procedures per 100,000 people in various countries in EMEA 2013
Exhibit 39: Number of coronary angiography procedures in various countries in EMEA 2006 and 2013 (in 100,000 population)
Exhibit 40: Angiography devices market in EMEA 2016-2021 ($ billions)
Exhibit 41: Angiography devices market in EMEA: Metrics analysis by countries
Exhibit 42: Market overview: Angiography devices market in Israel
Exhibit 43: Market overview: Angiography devices market in APAC
Exhibit 44: Angiography devices market in APAC 2016-2021 ($ billions)
Exhibit 45: Market overview: Angiography devices market in India
Exhibit 46: CROs that helped companies receive regulatory approvals for PCI devices
Exhibit 47: CROs that helped companies receive regulatory approvals for PCI devices
Exhibit 48: New market entrants
Exhibit 49: Impact of drivers
Exhibit 50: Product recalls: Angiography devices
Exhibit 51: Impact of drivers and challenges
Exhibit 52: Marketing and sales strategies of large and small companies
Exhibit 53: Acquisitions by some companies
Exhibit 54: Competitive structure analysis of global angiography devices market 2016
Exhibit 55: Competitive landscape analysis of global angiography devices market 2016
Exhibit 56: Abbott Laboratories: Strength assessment
Exhibit 57: Abbott Laboratories: Strategy assessment
Exhibit 58: Abbott Laboratories: Opportunity assessment
Exhibit 59: Boston Scientific: Strength assessment
Exhibit 60: Boston Scientific: Strategy assessment
Exhibit 61: Boston Scientic: Opportunity assessment
Exhibit 62: Cardinal Health: Strength assessment
Exhibit 63: Cardinal Health: Strategy assessment
Exhibit 64: Cardinal Health: Opportunity assessment
Exhibit 65: Medtronic: Strength assessment
Exhibit 66: Medtronic: Strategy assessment
Exhibit 67: Medtronic: Opportunity assessment
Exhibit 68: Key companies to watch
Exhibit 69: Other prominent vendors
